Information Technology (IT) laboratory equipment and services

Luxembourg Eurofins Technologies Tender

📄 Tender ID: 467928938 📅 Published: 01 Dec 2021

📋 Tender Overview

Eurofins Technologies continues to innovate and develop a wide range of diagnostic solutions for COVID-19 particularly in response to the threat of emerging mutations.In the past days researchers have identified a new SARS-CoV-2 variant with a concerningly high number of mutations in the spike protein. The variant was first identified in Botswana in November 2021 is spreading rapidly across South Africa and has been identified in travellers to Hong Kong.The variant is especially concerning as it contains more than 30 mutations to the spike protein the SARS-CoV-2 protein that recognises host cells and is the main target of the bodys natural or vaccine induced immune responses. Similar mutations have been found in variants such as Delta and Alpha and have been linked to heightened infection rates and potential resistance to infection-blocking antibodies 1. However the combination of these mutations seems to be unique to this variant and no related variants have so far been identified 2. It is therefore critical to quickly identify clusters to limit spread of this concerning variant. Eurofins through Gold Standard Diagnostics Europe provides the toolset to rapidly identify the variant B.1.1.529. GSD NovaType Select is a set of RT-PCR assays to specifically detect mutations in the genome of SARS-CoV-2 in around 1 hour much faster than genome sequencing methods.GSD NovaType Select P681H can differentiate variant B.1.1.529 from the currently dominant Delta variant and can be used as a large scale screening test for all PCR positive samples. For further confirmation all samples positive for the mutation P681H should be tested using GSD NovaType Select T478K and K417N to further differentiate B.1.1.529 from other circulating SARS-CoV-2 variants of concern 3.Gilles Martin Eurofins CEO said We continue to innovate to meet the ongoing challenges arising from the pandemic. I am very pleased with the speed at which we have brought to market a new test for the detection of this variant. We have maintained significant testing capacity across our markets which together with innovations such as this positions us very well to help deliver highly accurate variant-detecting COVID tests at significant scale to help navigate the pandemic.References1 Heavily mutated coronavirus variant puts scientists on alert article from Nature 25112021 available at httpswww.nature.comarticlesd41586-021-03552-w2 Urgent briefing on latest developments around the Covid-19 vaccination programme by South African Minister of Health and Deputy Minister of Health httpswww.youtube.comwatchvVh4XMueP1zQt709s3 WHO Tracking SARS-CoV-2 variants httpswww.who.intenactivitiestracking-SARS-CoV-2-variants

🔍 Key Information

📄
Tender Reference No.
467928938
📅
Publication Date
01 Dec 2021
🌐
Sector
Information Technology (IT)
📝
Notice Type
News
📍
Location
Luxembourg

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 01 Dec 2021
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country Luxembourg
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…